Cargando…
MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer’s Disease
Mild cognitive impairment (MCI) defines an intermediate state between normal ageing and dementia, including Alzheimer’s disease (AD). Identification of MCI subjects who will progress to AD (MCI-AD) is today of crucial importance, especially in light of the possible development of new pathogenic ther...
Autores principales: | De Felice, Bruna, Montanino, Concetta, Oliva, Mariano, Bonavita, Simona, Di Onofrio, Valeria, Coppola, Cinzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515963/ https://www.ncbi.nlm.nih.gov/pubmed/32737762 http://dx.doi.org/10.1007/s12035-020-02029-7 |
Ejemplares similares
-
Exploring Circulating Long Non-Coding RNAs in Mild Cognitive Impairment Patients’ Blood
por: De Felice, Bruna, et al.
Publicado: (2023) -
Circulating microRNAs in Hidradenitis Suppurativa
por: De Felice, Bruna, et al.
Publicado: (2022) -
Singular cases of Alzheimer’s disease disclose new and old genetic “acquaintances”
por: Coppola, Cinzia, et al.
Publicado: (2020) -
Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer’s and Parkinson’s Diseases
por: Hessen, Erik, et al.
Publicado: (2016) -
Progranulin levels in blood in Alzheimer's disease and mild cognitive impairment
por: Cooper, Yonatan A., et al.
Publicado: (2018)